Neurocrine Biosciences (NBIX) Ending Cash Balance (2009 - 2026)
Neurocrine Biosciences' Ending Cash Balance came in at $648 million for Q3 2026, up 86.1% from $348.2 million a year earlier and up 91.2% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Neurocrine Biosciences' Ending Cash Balance was $721 million, up 199.2% from FY2024.
- Ending Cash Balance carries a five-year compound annual growth rate of 30.5% (FY2020 to FY2025).
- Going back by year, Ending Cash Balance was $241 million in FY2024 (-7.0%), $259.1 million in FY2023 (-4.3%), $270.7 million in FY2022 (-21.3%) and $344 million in FY2021 (+80.8%).
- The five-year range for quarterly Ending Cash Balance is $111.6 million (Q1 2023) to $721 million (Q4 2025).
- Year-over-year, Ending Cash Balance has increased for four consecutive quarters, with growth averaging 46.3% over the last eight quarters.
- The fastest year-over-year change in Ending Cash Balance over five years came in Q1 2024 (growth of 262.3%), and the weakest in Q1 2023 (a decline of 59.9%).
- Business Quant data shows NBIX's Ending Cash Balance at $338.9 million (Q2 2026), $274.5 million (Q1 2026) and $721 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 648.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 648.00 Mn |
| Jun 30, 2026 | 338.90 Mn |
| Mar 31, 2026 | 274.50 Mn |
| Dec 31, 2025 | 721.00 Mn |
| Sep 30, 2025 | 348.20 Mn |
| Jun 30, 2025 | 272.00 Mn |
| Mar 31, 2025 | 202.10 Mn |
| Dec 31, 2024 | 241.00 Mn |
| Sep 30, 2024 | 357.10 Mn |
| Jun 30, 2024 | 147.70 Mn |
| Mar 31, 2024 | 404.30 Mn |
| Dec 31, 2023 | 259.10 Mn |
| Sep 30, 2023 | 301.70 Mn |
| Jun 30, 2023 | 168.20 Mn |
| Mar 31, 2023 | 111.60 Mn |
| Dec 31, 2022 | 270.70 Mn |
| Sep 30, 2022 | 220.00 Mn |
| Jun 30, 2022 | 171.10 Mn |
| Mar 31, 2022 | 278.00 Mn |
| Dec 31, 2021 | 344.00 Mn |
API Access
Neurocrine Biosciences Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();